Harry W. Flynn

About Harry W. Flynn

Harry W. Flynn’s published research in the last 12 months focuses on the clinical management, imaging, and outcomes of complex vitreoretinal disease and vision-threatening ocular infections, with emphasis on real-world complications, advanced retinal imaging, antimicrobial resistance, and patient safety. Articles include:

“Optic Pit Maculopathy Managed With Observation: Serial Optical Coherence Tomography Imaging of Fluctuating Macular Fluid,” Ophthalmic Surg Lasers Imaging Retina, 56, 374 (2025).

“Alternative photosensitizer penetration depth evaluation in ex vivo human eyes for photodynamic antimicrobial therapy,” Ther Deliv, 16, 519 (2025)

“Clinical Features and Outcomes of Late Recurrent Rhegmatogenous Retinal Detachment,” Retina, (2025).

“Recurrent Intraocular Hemorrhage after Scleral Sutured Intraocular Lens,” Ophthalmology, 132, e165 (2025).

“Temperature Excursion of Patient-Purchased Anti-VEGF Agents—A Cause for Concern?” JAMA Ophthalmol, 143, 174 (2025).

“Tractional Retinoschisis in Proliferative Diabetic Retinopathy Imaged With Swept-Source Optical Coherence Tomography Angiography,” Ophthalmic Surg Lasers Imaging Retina, 56, 244 (2025).

“Demarcation Laser Photocoagulation for Rhegmatogenous Retinal Detachment: Outcomes in Symptomatic and Asymptomatic Patients,” Case Rep Ophthalmol, 16, 114 (2025).

BR Lin et al.,Coherence Tomography Angiography: Two Case Reports,” Case Rep Ophthalmol, 16, 274 (2025).

“Photodynamic antimicrobial therapy with Erythrosin B, Eosin Y, and Rose Bengal for the inhibition of fungal keratitis isolates: An in vitro study,” J Photochem Photobiol B, 263, 113090 (2025).

“Retinal Vasculitis in the Setting of Mycobacterium tuberculosis Exposure: Clinical Course and Management of Three Cases,” Case Rep Ophthalmol, 16, 18 (2025).

Harry W.. Flynn comments: “The motivation for my career path has been guided by the pleasure of patient care, teaching, and clinical research. With the help of this entire team of people, I have authored or co-authored over 774 papers in peer-reviewed journals, approximately 300 papers in non-peer reviewed publications, 10 books and over 135 book chapters. This could not have been accomplished without the help of residents, fellows, medical students, and my colleagues.

At various meetings including the AAO, ARVO, and subspecialty societies, I have presented clinical research outcomes. It is a unique experience to be able to divide my time between clinical care, teaching and clinical research. Over the years, I have participated in the ETDRS and the DRCR (Diabetic Retinopathy Clinical Research) Data & Safety Monitoring Committee. At the University of Miami, I have been a part of the University Credentials Committee and headed the Infection Control Committee of our hospital. In recent years my clinical research has been focused on endophthalmitis and infectious diseases. It has been a source of great pleasure and pride to participate in all of these activities during the past 47 years.”